Technology Industry
Industry: Email Alert RSS FeedBT Catalyst
View more issues: July-August 2002, Sept 2002, Dec 2002
Articles in Oct-Nov 2002 issue of BT Catalyst
- North Carolina Biotechnology Center
- Tranzyme searches for neurosensory targets through industry partnering
- Closure Medical Corp
- Targacept acquires marketed drug to expand CNS development portfolio
- Syngenta Crop Protection Inc
- Banner Pharmacaps expands presence in triad: will add close to 100 jobs at new manufacturing headquarters
- Bayer BP receives FDA approval for manufacturing processes
- StemCo Biomedical Inc. of Durham, Saneron CCEL Therapeutics Inc. of Temple Terrace, Fla., and the University of South Florida recently received a $180,000 Florida High Technology Corridor grant to collaborate in several joint studies on the use of stem c
- UNCW to partner with aaiPharma on tech. transfer
- Two companies raise a total of $10.5M
- Nobex Corp
- Gentris Corp. of Research Triangle Park and Promega Corp. of Madison, Wis., have agreed to jointly pursue development of clinical pharmacogenomic products
- FDA approves ENOX
- ChemCodes
- Biolex Inc. of Pittsboro and Switzerland-based Debiopharm S.A. haveformed a collaboration
- Fuzeon NDA submitted
- Triangle Pharmaceuticals Inc
- Calendar
- CiVentiChem opens R&D facility in India
- Coviracil NDA filed
- TriPath Imaging Inc
- Wood named vp of business and tech. development
- Research Triangle Park
- Paradigm secures $23.8M NIEHS contract
- BT Catalyst
- N.C. bioprocessing group formed
- Norak Biosciences Inc